Cencora, Inc.

Alpha Score of 52 reflects moderate overall profile with weak momentum, moderate value, moderate quality, moderate sentiment.

Cencora, Inc. is a leading global pharmaceutical solutions organization that distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies, and equipment to healthcare providers worldwide. It serves acute care hospitals, health systems, independent and chain retail pharmacies, mail-order facilities, physicians, clinics, nursing and assisted living centers, as well as long-term care, workers' compensation, and specialty drug patients. The company provides drug distribution, consulting services related to medical business operations, patient services, and innovative partnerships with manufacturers, providers, and pharmacies to enhance product access and efficiency throughout the healthcare supply chain. Cencora offers industry-leading solutions for human health and animal health, accelerating better health outcomes from concept to delivery with global support and local expertise in more than 50 countries. Its operations include logistics, warehousing, and support for biopharma breakthroughs, enabling life-changing therapies to reach patients effectively. Headquartered in Conshohocken, Pennsylvania, Cencora plays a vital role in transforming healthcare delivery and fostering healthier futures for people and animals.